RecallRadar

FDA Drug recall D-0956-2016

Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen, Rx only, Novo Nordisk Inc., Plainsboro, NJ --- NDC 0169-7…

On 2016-06-15 the FDA classified a Class II recall of Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen, Rx only, Novo Nordisk Inc., Plainsboro, NJ --- NDC 0169-7… by Novo Nordisk, citing defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0956-2016
ClassificationClass II
Statusterminated
Initiated2016-04-27
Published2016-06-15
Last updated2026-09-13 11:51 UTC
CompanyNovo Nordisk
DistributionUS

Product

Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen, Rx only, Novo Nordisk Inc., Plainsboro, NJ --- NDC 0169-7703-21

Reason

Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step

Identifiers

ndc0169-7704-21
ndc0169-7704-92
ndc0169-7705-21
ndc0169-7705-92
ndc0169-7708-21
ndc0169-7708-92
ndc0169-7703-11
ndc0169-7703-91
ndc0169-7703-21
ndc0169-7703-92
code_infoLot Number FC70222

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0956-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.